Skip to main content

Advertisement

SpringerLink
Log in

Imaging patterns of intraductal papillary mucinous neoplasms of the pancreas: An illustrated discussion of the International Consensus Guidelines for the Management of IPMN

  • Pictorial Essay
  • Published:
Abdominal Imaging Aims and scope Submit manuscript

Abstract

Intraductal papillary mucinous neoplasms (IPMN) are being diagnosed with increasing frequency, necessitating an algorithm to help stratify patients into low- and high-risk groups, for follow-up versus more invasive evaluation. New evidence concerning their natural history and overall risk of malignancy has emerged since the 2006 International Association of Pancreatology consensus guidelines, prompting an update in 2012, that distinguishes radiologic ‘worrisome features’ from ‘high-risk stigmata’. The aim of this article is to illustrate, with case examples, the variable imaging patterns of IPMN and how their radiologic features, such as cyst size and mural nodules, are interpreted in the context of the new 2012 guidelines. The 2012 and 2006 guidelines will be compared and discussed with reference to additional studies that have since been published. Despite these guidelines, lingering uncertainty remains about the natural history of IPMN, a source of unease to both radiologists and referring clinicians alike, mandating further refinement of clinical and radiologic parameters predictive of malignancy. Emerging data regarding the risk of extrapancreatic malignancy, as well as synchronous or metachronous pancreatic ductal adenocarcinoma remote in location from a branch duct IPMN are also reviewed. With the expanding research and evolving understanding of this clinicopathologic entity across the globe, radiologists will continue to play an important role in the management of patients with IPMN.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11
Fig. 12
Fig. 13
Fig. 14

Similar content being viewed by others

References

  1. Laffan TA, Horton KM, Klein AP, et al. (2008) Prevalence of unsuspected pancreatic cysts on MDCT. AJR Am J Roentgenol. 191(3):802–807.

    Article  PubMed Central  PubMed  Google Scholar 

  2. Zhang XM, Mitchell DG, Dohke M, Holland GA, Parker L (2002) Pancreatic cysts: depiction on single-shot fast spin-echo MR images. Radiology. 223(2):547–553.

    Article  PubMed  Google Scholar 

  3. Fernandez-del Castillo C, Targarona J, Thayer SP, et al. (2003) Incidental pancreatic cysts: clinicopathologic characteristics and comparison with symptomatic patients. Arch Surg 138(4):42–427.

    Google Scholar 

  4. Gaujoux S, Brennan MF, Gonen M, et al. (2011) Cystic lesions of the pancreas: changes in the presentation and management of 1,424 patients at a single institution over a 15-year time period. J Am Coll Surg 212(4):590–600.

    Article  PubMed  Google Scholar 

  5. Adsay NV (2008) Cystic neoplasia of the pancreas: pathology and biology. J Gastrointest Surg. 12(3):401–404.

    Article  PubMed  Google Scholar 

  6. He J, Ahuja N, Makary MA, et al. (2014) 2564 resected periampullary adenocarcinomas at a single institution: trends over three decades. HPB (Oxford). 16(1):83–90.

    Article  PubMed Central  PubMed  Google Scholar 

  7. Correa-Gallego C, Ferrone CR, Thayer SP, Wargo JA, Warshaw AL (2010) Fernandez-Del Castillo C. Incidental pancreatic cysts: do we really know what we are watching? Pancreatology. 10(2–3):144–150.

    Article  PubMed Central  PubMed  Google Scholar 

  8. Sahani DV, Sainani NI, Blake MA, et al. (2011) Prospective evaluation of reader performance on MDCT in characterization of cystic pancreatic lesions and prediction of cyst biologic aggressiveness. AJR Am J Roentgenol 197(1):W53–W61.

    Article  PubMed  Google Scholar 

  9. Tanaka M, Chari S, Adsay V, et al. (2006) International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology. 6(1–2):17–32.

    Article  PubMed  Google Scholar 

  10. Tanaka M, Fernandez-del Castillo C, Adsay V, et al. (2012) International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology 12(3):183–197.

    Article  PubMed  Google Scholar 

  11. Berland LL, Silverman SG, Gore RM, et al. (2010) Managing incidental findings on abdominal CT: white paper of the ACR incidental findings committee. J Am Coll Radiol. 7(10):754–773.

    Article  PubMed  Google Scholar 

  12. Ohhashi K, Murakami Y, Maruyama M, et al. (1982) Four cases of mucous secreting pancreatic cancer. Prog Dig Endosc. 20:348–351.

    Google Scholar 

  13. Adsay NV, Jukushima N, Furukawa T, et al. (2010) Intraductal neoplasm of the pancreas. In: Bosman FT, Carneiro F, Hruban RH, Theise ND (eds) WHO classification of tumors of the digestive system. Lyon: WHO Press, pp 304–313.

    Google Scholar 

  14. Furukawa T, Hatori T, Fujita I, et al. (2011) Prognostic relevance of morphological types of intraductal papillary mucinous neoplasms of the pancreas. Gut. 60(4):509–516.

    Article  PubMed  Google Scholar 

  15. Canto MI, Hruban RH, Fishman EK, et al. (2012) Frequent detection of pancreatic lesions in asymptomatic high-risk individuals. Gastroenterology. 142(4):796–804.

    Article  PubMed Central  PubMed  Google Scholar 

  16. Waters JA, Schmidt CM, Pinchot JW, et al. (2008) CT vs MRCP: optimal classification of IPMN type and extent. J Gastrointest Surg. 12(1):101–109.

    Article  PubMed  Google Scholar 

  17. Rautou PE, Levy P, Vullierme MP, et al. (2008) Morphologic changes in branch duct intraductal papillary mucinous neoplasms of the pancreas: a midterm follow-up study. Clin Gastroenterol Hepatol. 6(7):807–814.

    Article  PubMed  Google Scholar 

  18. Goh BK, Tan DM, Thng CH, et al. (2014) Are the Sendai and Fukuoka Consensus Guidelines for Cystic Mucinous Neoplasms of the Pancreas Useful in the Initial Triage of all Suspected Pancreatic Cystic Neoplasms? A Single-Institution Experience with 317 Surgically-Treated Patients. Ann Surg Oncol. 21(6):1919–1926.

    Article  PubMed  Google Scholar 

  19. Sahora K, Mino-Kenudson M, Brugge W, et al. (2013) Branch duct intraductal papillary mucinous neoplasms: does cyst size change the tip of the scale? A critical analysis of the revised international consensus guidelines in a large single-institutional series. Ann Surg. 258(3):466–475.

    Article  PubMed  Google Scholar 

  20. Kim KW, Park SH, Pyo J, et al. (2014) Imaging Features to Distinguish Malignant and Benign Branch-Duct Type Intraductal Papillary Mucinous Neoplasms of the Pancreas: a Meta-analysis. Ann Surg. 259(1):72–81.

    Article  PubMed  Google Scholar 

  21. Raman SP, Kawamoto S, Blackford A, et al. (2013) Histopathologic findings of multifocal pancreatic intraductal papillary mucinous neoplasms on CT. AJR Am J Roentgenol. 200(3):563–569.

    Article  PubMed  Google Scholar 

  22. Schmidt CM, White PB, Waters JA, et al. (2007) Intraductal papillary mucinous neoplasms: predictors of malignant and invasive pathology. Ann Surg 246(4):644–651 (discussion 51–54).

    Article  PubMed  Google Scholar 

  23. Anand N, Sampath K, Wu BU (2013) Cyst features and risk of malignancy in intraductal papillary mucinous neoplasms of the pancreas: a meta-analysis. Clin Gastroenterol Hepatol 11(8):913–921 (quiz e59-60)

    Article  PubMed  Google Scholar 

  24. Ferrone CR, Correa-Gallego C, Warshaw AL, et al. (2009) Fernandez-Del Castillo C. Current trends in pancreatic cystic neoplasms. Arch Surg. 144(5):448–454.

    Article  PubMed Central  PubMed  Google Scholar 

  25. Correa-Gallego C, Do R, Lafemina J, et al. (2013) Predicting dysplasia and invasive carcinoma in intraductal papillary mucinous neoplasms of the pancreas: development of a preoperative nomogram. Ann Surg Oncol. 20(13):4348–4355.

    Article  PubMed  Google Scholar 

  26. Shimizu Y, Yamaue H, Maguchi H, et al. (2013) Predictors of malignancy in intraductal papillary mucinous neoplasm of the pancreas: analysis of 310 pancreatic resection patients at multiple high-volume centers. Pancreas. 42(5):883–888.

    Article  CAS  PubMed  Google Scholar 

  27. Hwang DW, Jang JY, Lee SE, et al. (2012) Clinicopathologic analysis of surgically proven intraductal papillary mucinous neoplasms of the pancreas in SNUH: a 15-year experience at a single academic institution. Langenbecks Arch Surg. 397(1):93–102.

    Article  PubMed  Google Scholar 

  28. Do RK, Katz SS, Gollub MJ, et al. (in press) Interobserver agreement for detection of malignant features of intraductal papillary mucinous neoplasm of the pancreas on multi detector CT. Am J Roentgenol.

  29. Kawamoto S, Lawler LP, Horton KM, et al. (2006) MDCT of intraductal papillary mucinous neoplasm of the pancreas: evaluation of features predictive of invasive carcinoma. AJR Am J Roentgenol. 186(3):687–695.

    Article  PubMed  Google Scholar 

  30. Sugiyama M, Izumisato Y, Abe N, et al. (2003) Predictive factors for malignancy in intraductal papillary-mucinous tumours of the pancreas. Br J Surg. 90(10):1244–1249.

    Article  CAS  PubMed  Google Scholar 

  31. Brugge WR, Lewandrowski K, Lee-Lewandrowski E, et al. (2004) Diagnosis of pancreatic cystic neoplasms: a report of the cooperative pancreatic cyst study. Gastroenterology. 126(5):1330–1336.

    Article  PubMed  Google Scholar 

  32. Allen PJ, D’Angelica M, Gonen M, et al. (2006) A selective approach to the resection of cystic lesions of the pancreas: results from 539 consecutive patients. Ann Surg. 244(4):572–582.

    PubMed Central  PubMed  Google Scholar 

  33. Fritz S, Klauss M, Bergmann F, et al. (2012) Small (Sendai negative) branch-duct IPMNs: not harmless. Ann Surg. 256(2):313–320.

    Article  PubMed  Google Scholar 

  34. Sahani DV, Saokar A, Hahn PF, Brugge WR (2006) Fernandez-Del Castillo C. Pancreatic cysts 3 cm or smaller: how aggressive should treatment be? Radiology. 238(3):912–919.

    Article  PubMed  Google Scholar 

  35. Correa-Gallego C, Brennan MF, Fong Y, et al. (2014) Liberal Resection for (Presumed) Sendai Negative Branch-Duct Intraductal Papillary Mucinous Neoplasms- Also Not Harmless. Ann Surg 259(3):e45.

    Article  PubMed  Google Scholar 

  36. Fernandez-Del Castillo CF (2014) Thayer SP, Ferrone CR, Wargo J. Surgery for Small and Asymptomatic Branch-Duct IPMNs. Ann Surg. 259(3):e47.

    Article  PubMed  Google Scholar 

  37. Wong J, Weber J, Centeno BA, et al. (2013) High-grade dysplasia and adenocarcinoma are frequent in side-branch intraductal papillary mucinous neoplasm measuring less than 3 cm on endoscopic ultrasound. J Gastrointest Surg 17(1):78–84 (discussion p 5).

    Article  PubMed  Google Scholar 

  38. Suzuki R, Thosani N, Annangi S, et al. (2014) Diagnostic yield of endoscopic retrograde cholangiopancreatography-based cytology for distinguishing malignant and benign intraductal papillary mucinous neoplasm: Systematic review and meta-analysis. Dig Endosc. doi:10.1111/den.12230.

    Google Scholar 

  39. Kang MJ, Jang JY, Kim SJ, et al. (2011) Cyst growth rate predicts malignancy in patients with branch duct intraductal papillary mucinous neoplasms. Clin Gastroenterol Hepatol. 9(1):87–93.

    Article  PubMed  Google Scholar 

  40. Ammori JB, Do RK, Brennan MF, et al. (2014) Uncinate Duct Dilation in Intraductal Papillary Mucinous Neoplasms of the Pancreas: a Radiographic Finding with Potentially Increased Malignant Potential. J Gastrointest Surg. 18(5):911–916.

    Article  PubMed  Google Scholar 

  41. Kang KM, Lee JM, Shin CI, et al. (2013) Added value of diffusion-weighted imaging to MR cholangiopancreatography with unenhanced mr imaging for predicting malignancy or invasiveness of intraductal papillary mucinous neoplasm of the pancreas. J Magn Reson Imaging. 38(3):555–563.

    Article  PubMed  Google Scholar 

  42. Sandrasegaran K, Akisik FM, Patel AA, et al. (2011) Diffusion-weighted imaging in characterization of cystic pancreatic lesions. Clin Radiol. 66(9):808–814.

    Article  CAS  PubMed  Google Scholar 

  43. Baiocchi GL, Bertagna F, Gheza F, et al. (2012) Searching for indicators of malignancy in pancreatic intraductal papillary mucinous neoplasms: the value of 18 FDG–PET confirmed. Ann Surg Oncol. 19(11):3574–3580.

    Article  PubMed  Google Scholar 

  44. Pedrazzoli S, Sperti C, Pasquali C, Bissoli S, Chierichetti F (2011) Comparison of International Consensus Guidelines versus 18-FDG PET in detecting malignancy of intraductal papillary mucinous neoplasms of the pancreas. Ann Surg. 254(6):971–976.

    Article  PubMed  Google Scholar 

  45. Cowan RW, Maitra A (2014) Genetic progression of pancreatic cancer. Cancer J 20(1):80–84.

    Article  CAS  PubMed  Google Scholar 

  46. Hruban RH, Takaori K, Canto M, et al. (2007) Clinical importance of precursor lesions in the pancreas. J Hepatobiliary Pancreat Surg. 14(3):255–263.

    Article  PubMed  Google Scholar 

  47. Landa J, Allen P, D’Angelica M, Schwartz LH (2009) Recurrence patterns of intraductal papillary mucinous neoplasms of the pancreas on enhanced computed tomography. J Comput Assist Tomogr. 33(6):838–843.

    Article  PubMed  Google Scholar 

  48. White R, D’Angelica M, Katabi N, et al. (2007) Fate of the remnant pancreas after resection of noninvasive intraductal papillary mucinous neoplasm. J Am Coll Surg 204(5):987–993 (discussion 93–95).

    Article  PubMed  Google Scholar 

  49. He J, Cameron JL, Ahuja N, et al. (2013) Is it necessary to follow patients after resection of a benign pancreatic intraductal papillary mucinous neoplasm? J Am Coll Surg 216(4):657–665 (discussion 65–67).

    Article  PubMed Central  PubMed  Google Scholar 

  50. Kang MJ, Jang JY, Lee KB, Chang YR, Kwon W, Kim SW (2013) Long-term prospective cohort study of patients undergoing pancreatectomy for intraductal papillary mucinous neoplasm of the pancreas: implications for postoperative surveillance. Ann Surg. doi:10.1097/SLA.0000000000000470.

  51. Tanno S, Nakano Y, Sugiyama Y, et al. (2010) Incidence of synchronous and metachronous pancreatic carcinoma in 168 patients with branch duct intraductal papillary mucinous neoplasm. Pancreatology 10(2–3):173–178.

    Article  PubMed  Google Scholar 

  52. Lafemina J, Katabi N, Klimstra D, et al. (2013) Malignant progression in IPMN: a cohort analysis of patients initially selected for resection or observation. Ann Surg Oncol. 20(2):440–447.

    Article  CAS  PubMed  Google Scholar 

  53. Sawai Y, Yamao K, Bhatia V, et al. (2010) Development of pancreatic cancers during long-term follow-up of side-branch intraductal papillary mucinous neoplasms. Endoscopy 42(12):1077–1084.

    Article  CAS  PubMed  Google Scholar 

  54. Tada M, Kawabe T, Arizumi M, et al. (2006) Pancreatic cancer in patients with pancreatic cystic lesions: a prospective study in 197 patients. Clin Gastroenterol Hepatol. 4(10):1265–1270.

    Article  PubMed  Google Scholar 

  55. Uehara H, Nakaizumi A, Ishikawa O, et al. (2008) Development of ductal carcinoma of the pancreas during follow-up of branch duct intraductal papillary mucinous neoplasm of the pancreas. Gut. 57(11):1561–1565.

    Article  CAS  PubMed  Google Scholar 

  56. Larghi A, Panic N, Capurso G, et al. (2013) Prevalence and risk factors of extrapancreatic malignancies in a large cohort of patients with intraductal papillary mucinous neoplasm (IPMN) of the pancreas. Ann Oncol. 24(7):1907–1911.

    Article  CAS  PubMed  Google Scholar 

  57. Kawakubo K, Tada M, Isayama H, et al. (2013) Risk for mortality from causes other than pancreatic cancer in patients with intraductal papillary mucinous neoplasm of the pancreas. Pancreas. 42(4):687–691.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA

    Naomi M. Campbell, Seth S. Katz, Joanna G. Escalon & Richard K. Do

Authors
  1. Naomi M. Campbell
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Seth S. Katz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Joanna G. Escalon
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Richard K. Do
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Naomi M. Campbell.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Campbell, N.M., Katz, S.S., Escalon, J.G. et al. Imaging patterns of intraductal papillary mucinous neoplasms of the pancreas: An illustrated discussion of the International Consensus Guidelines for the Management of IPMN. Abdom Imaging 40, 663–677 (2015). https://doi.org/10.1007/s00261-014-0236-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00261-014-0236-4

Keywords

Search

Navigation